Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate

Authors

Keywords

Journal

Volume 7, Issue 9, Pages 862-867

Publisher

American Chemical Society (ACS)

Online

2016-07-23

DOI

10.1021/acsmedchemlett.6b00238

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now